On August 1, 2019, Jiangxi Zhongyuan Pharmaceutical Co., Ltd. and Jiangxi Xinganjian Pharmaceutical Co., Ltd. jointly integrated their sales operations. This marks a transformation and upgrading for the two production-oriented enterprises. In the future, the OTC generic drugs produced by the two factories will be sold exclusively through their subsidiary, Jiangxi Renhua Pharmaceutical Co., Ltd. Additionally, the sales team has undergone integration and training, with a focus on market segmentation and product analysis, aiming to build a passionate and capable professional sales team.